Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer
评估洛拉替尼对晚期非小细胞肺癌患者CYP2B6、CYP2C9、UGT和P-糖蛋白底物的影响
期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-023-01309-4
Chen, Joseph; Bearz, Alessandra; Kim, Dong-Wan; Mamdani, Hirva; Bauman, Jessica; Chiari, Rita; Ou, Sai-Hong Ignatius; Solomon, Benjamin J; Soo, Ross A; Felip, Enriqueta; Shaw, Alice T; Thurm, Holger; Clancy, Jill S; Lee, Kimberly; O'Gorman, Melissa; Tanski, Cherie; Pithavala, Yazdi K